Flick Gocke Schaumburg advises MEDICE on strategic partnership with HMNC Brain Health

Flick Gocke Schaumburg has advised MEDICE – The Health Family on a strategic partnership with HMNC Holding GmbH to advance treatments for depression. The advisory services focused on the participation of Precision Psychiatry Investment GmbH, a sister company of MEDICE, in the current funding round for HMNC Holding GmbH.

The collaboration aims to accelerate the development of innovative treatments for depression. Teams from HMNC and MEDICE are working on the clinical development and regulatory approval of novel ketamine-based therapies. 

Advisors to MEDICE: Flick Gocke Schaumburg

Dr. Bettina Wirth-Duncan (lead; private equity/M&A), Matthias Full, Corina Hackbarth, Fabian Mang (all M&A tax), Dr. Florian Haus (antitrust law); associates: Dr. Alexander Heinen, Dr. Julius Simon, Catherine-Louise Breuninger (all private equity/M&A), Tomke Zeeh (M&A tax), Dr. Valentin Urban (antitrust law)

Based in Iserlohn, MEDICE is a long-established German family business under the umbrella brand MEDICE – The Health Family. It has around 1,300 employees worldwide, and is now run by the third generation of the founding family. It provides pharmaceutical and digital healthcare solutions in mental health and renal care (nephrology and urology), and supplies over-the-counter respiratory, women’s, gut and skin health products.

Based in Munich, HMNC Holding GmbH is a pioneer in developing biomarker-based methods for the precision treatment of psychiatric disorders. <<<